RNA therapeutics designed to restore expression of silenced genes
CV
CDP Venture Capital
Activity from announced rounds
Activity in this selectionopenai-0702931a
- Rounds participated in
- 4
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $64.4M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionAptadir Therapeutics
€40MSeed
ParticipantClastix
Clastix builds Kubernetes infrastructure software, including Kamaji for hosted tenant control planes and kMetal for bare-metal cluster operations.
€2.9MSeed
LeadTundr
Tundr gives employers a digital employee-benefits program built around a Mastercard for fringe benefits, a flexible-benefits app for employees and a management console for HR teams.
€11.6MSeries A
ParticipantHolifya
Holifya is a digital clinic for obesity and metabolic health that combines physician-supervised care with nutrition and behavioral support. Clinicians assess each patient and may prescribe GLP-1/GIP medicines when medically appropriate; the medication sits within an ongoing programme of personalized eating, activity and follow-up rather than being dispensed as a standalone product.
€2MFunding
Participant